Try our Advanced Search for more refined results

January 23, 2020

Tollen v. Geron Corporation et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 24, 2023

    Geron Investors' Attys Get $4.3M From $24M Stock-Drop Deal

    A California federal judge on Thursday applauded attorneys for investors in Geron Corp. as he gave final approval to a settlement with the biotechnology company and its CEO over claims they hid negative results of a clinical drug trial, saying, "This is not the greatest case ever, and you managed to get $24 million out of it."

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login